[ad_1] Needham upgraded Penumbra Inc PEN to Buy from Hold, with a price target of $244. The analyst notes that management indicated PEN is seeing stronger growth in 3Q22 due to…
[ad_1] AstraZeneca plc AZN and Merck & Co Inc MRK announced long-term follow-up results from the Phase 3 PAOLA-1 and SOLO-1 trials in first-line advanced ovarian cancer evaluating Lynparza (Olaparib) as a combination and…
[ad_1] Reuters iPhone 14 Will Be Available In Russia Despite Apple’s Exit From The Country, Says Trade Minister The newly-launched iPhone 14 and other Apple Inc AAPL products will…
[ad_1] In separate SEC documents, Target Corporation TGT filed to raise about $1 billion in bonds due 2032 and McDonald’s Corp MCD about $1.5 billion in two-part bonds due 2052 and 2032. As per the Reuters…
[ad_1] Reuters EQT Corp Close To Buying THQ Appalachia U.S.-based natural gas producer EQT Corporation EQT is in advanced talks to purchase exploration and production company THQ Appalachia I…
[ad_1] The FDA approved AstraZeneca plc’s AZN Imfinzi (durvalumab) for locally advanced or metastatic biliary tract cancer (BTC) in combination with chemotherapy (gemcitabine plus cisplatin). The approval was based on the…
[ad_1] Shell Plc SHEL is looking for a new CEO, as Chief Executive Ben van Beurden is preparing to step down next year after nearly a decade, two company sources told…
[ad_1] by Vandana Singh, Benzinga Editor August 30, 2022 3:00 PM | 1 min read RBC Capital Markets cut the price target on Catalent Inc CTLT from $155 to $125 with an Outperform…
[ad_1] The FDA has accepted for priority review Sanofi SA’s SNY marketing application for efanesoctocog alfa (BIVV001) for hemophilia A, a rare bleeding disorder. The target action date for the FDA…
[ad_1] Longeveron Inc. LGVN announced that the European Patent Office (EPO) had issued a notice of its intent to grant the Company a patent (EP Application No. 15861319.0) related to…
[ad_1] Longeveron Inc. LGVN announced that the European Patent Office (EPO) had issued a notice of its intent to grant the Company a patent (EP Application No. 15861319.0) related to…
[ad_1] Longeveron Inc. LGVN announced that the European Patent Office (EPO) had issued a notice of its intent to grant the Company a patent (EP Application No. 15861319.0) related to…
[ad_1] Owl Creek Asset Management L.P. sent a letter to Cano Health Inc CANO board strongly encouraging the company to pursue strategic alternatives, including a potential sale. Owl Creek owns around a 3.75% stake…
[ad_1] In 2017, 41.9% of Americans experienced some level of obesity. Adults experiencing obesity in 2019 spent an average of $1,861 more on medical expenses than people with a healthy…
[ad_1] © 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the…
[ad_1] © 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the…
[ad_1] © 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the…
[ad_1] Here’s a roundup of top developments in the biotech space over the last 24 hours: Mersana, GSK Ink $1.36B Biobuck Deal For Cancer-Focused Therapy Mersana Therapeutics Inc MRSN announced a global…
[ad_1] Here’s a roundup of top developments in the biotech space over the last 24 hours: FDA Signs Off Marker Therapeutics Cell Therapy Study In Lymphoma Setting The FDA cleared Marker Therapeutics…
[ad_1] Here’s a roundup of top developments in the biotech space over the last 24 hours: Alnylam Reports Upbeat Data From Amyloidosis Study Alnylam Pharmaceuticals Inc’s ALNY APOLLO-B Phase 3 study of…
[ad_1] Axonics Inc AXNX reported a 50% Y/Y increase in Q2 sales to $69 million, beating the consensus of $59 million. Sacral neuromodulation (SNM) revenue was $55.8 million, and Bulkamid…
[ad_1] The Securities and Exchange Commission has charged 11 people for their roles in creating and promoting an allegedly fraudulent crypto-focused pyramid & Ponzi scheme that raised more than $300 million…
[ad_1] Amgen Inc AMGN will fight Internal Revenue Service over the company’s international tax strategy and $10.7 billion in back taxes and penalties, Wall Street Journal reported. The IRS agency…
[ad_1] Kazia Therapeutics Limited KZIA said GBM AGILE, a pivotal study for paxalisib in newly diagnosed glioblastoma, did not meet pre-defined criteria for continuing to a second stage. Patients enrolled in…
[ad_1] The FDA has lifted the clinical hold on Celyad Oncology SA’s CYAD CYAD-101-002 (KEYNOTE-B79) Phase 1b trial after the company made changes to the eligibility criteria for the trial. “We remain…